loadpatents
name:-0.037739038467407
name:-0.019966125488281
name:-0.035531044006348
Liang; Yanke Patent Filings

Liang; Yanke

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liang; Yanke.The latest application filed is for "uses of salt-inducible kinase (sik) inhibitors for treating osteoporosis".

Company Profile
31.18.36
  • Liang; Yanke - Belmont MA
  • Liang; Yanke - Brookline MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis
App 20220305016 - Wein; Marc ;   et al.
2022-09-29
Inhibitors Of Cyclin-dependent Kinase 7 And Uses Thereof
App 20220281874 - Zhang; Tinghu ;   et al.
2022-09-08
Uses Of Pyrimidopyrimidinones As Sik Inhibitors
App 20220133736 - Fisher; David E. ;   et al.
2022-05-05
Degradation Of Cyclin-dependent Kinase 8 (cdk8) By Conjugation Of Cdk8 Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20220112191 - Gray; Nathanael S. ;   et al.
2022-04-14
Uses of pyrimidopyrimidinones as SIK inhibitors
Grant 11,285,158 - Fisher , et al. March 29, 2
2022-03-29
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use
Grant 11,247,991 - Gray , et al. February 15, 2
2022-02-15
Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis
Grant 11,241,435 - Wein , et al. February 8, 2
2022-02-08
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7)
App 20220024929 - Gray; Nathanael S. ;   et al.
2022-01-27
Spirocyclic degronimers for target protein degradation
Grant 11,185,592 - Phillips , et al. November 30, 2
2021-11-30
Degradation Of Cyclin-dependent Kinase 4/6 (cdk4/6) By Conjugation Of Cdk4/6 Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20210340140 - GRAY; NATHANAEL S. ;   et al.
2021-11-04
Imidazolyl Kinase Inhibitors And Uses Thereof
App 20210147388 - Gray; Nathanael S. ;   et al.
2021-05-20
Bicyclic Urea Kinase Inhibitors And Uses Thereof
App 20210147425 - Gray; Nathanael S. ;   et al.
2021-05-20
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7)
App 20210115051 - Gray; Nathanael S. ;   et al.
2021-04-22
Spirocyclic Degronimers For Target Protein Degradation
App 20210106688 - Phillips; Andrew J. ;   et al.
2021-04-15
Imidazolyl kinase inhibitors and uses thereof
Grant 10,975,058 - Gray , et al. April 13, 2
2021-04-13
Bicyclic urea kinase inhibitors and uses thereof
Grant 10,954,242 - Gray , et al. March 23, 2
2021-03-23
Compounds
App 20210079005 - Duplessis; Martin ;   et al.
2021-03-18
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide Compounds
App 20210070739 - Duplessis; Martin ;   et al.
2021-03-11
Degradation Of Cyclin-dependent Kinase 8 (cdk8) By Conjugation Of Cdk8 Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20210040093 - GRAY; Nathanael S. ;   et al.
2021-02-11
Heterocyclic degronimers for target protein degradation
Grant 10,905,768 - Phillips , et al. February 2, 2
2021-02-02
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
Grant 10,882,848 - Duplessis , et al. January 5, 2
2021-01-05
Inhibitors of cyclin-dependent kinase 7 (CDK7)
Grant 10,870,651 - Gray , et al. December 22, 2
2020-12-22
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use
Grant 10,865,205 - Gray , et al. December 15, 2
2020-12-15
Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use
Grant 10,865,204 - Gray , et al. December 15, 2
2020-12-15
C3-carbon linked glutarimide degronimers for target protein degradation
Grant 10,849,982 - Phillips , et al. December 1, 2
2020-12-01
Bifunctional Molecules That Degrade Egfr
App 20200361930 - Duplessis; Martin ;   et al.
2020-11-19
Uses Of Salt-inducible Kinase (sik) Inhibitors
App 20200338087 - Shamji; Alykhan ;   et al.
2020-10-29
Bicyclic Urea Kinase Inhibitors And Uses Thereof
App 20200317675 - GRAY; Nathanael S. ;   et al.
2020-10-08
Bifunctional Inhibitors With Egfr Having A E3 Ubiquitin Ligase Moiety
App 20200308171 - Jaeschke; Georg ;   et al.
2020-10-01
Uses Of Pyrimidopyrimidinones As Sik Inhibitors
App 20200253981 - Kind Code
2020-08-13
Uses Of Salt-inducible Kinase (sik) Inhibitors For Treating Osteoporosis
App 20200179387 - Wein; Marc ;   et al.
2020-06-11
Spirocyclic degronimers for target protein degradation
Grant 10,660,968 - Phillips , et al.
2020-05-26
Heterocyclic degronimers for target protein degradation
Grant 10,646,575 - Phillips , et al.
2020-05-12
N/o-linked Degrons And Degronimers For Protein Degradation
App 20200140456 - Phillips; Andrew J. ;   et al.
2020-05-07
Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use
Grant 10,532,103 - Gray , et al. Ja
2020-01-14
Imidazolyl Kinase Inhibitors And Uses Thereof
App 20190367487 - Gray; Nathanael S. ;   et al.
2019-12-05
Uses Of Salt-inducible Kinase (sik) Inhibitors
App 20190343842 - Shamji; Alykhan ;   et al.
2019-11-14
Macrocyclic kinase inhibitors and uses thereof
Grant 10,457,691 - Gray , et al. Oc
2019-10-29
Bicyclic Urea Kinase Inhibitors And Uses Thereof
App 20190315752 - GRAY; Nathanael S. ;   et al.
2019-10-17
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide Compounds
App 20190308955 - Duplessis; Martin ;   et al.
2019-10-10
Imidazolyl kinase inhibitors and uses thereof
Grant 10,287,268 - Gray , et al.
2019-05-14
Uses of salt-inducible kinase (SIK) inhibitors
Grant 10,265,321 - Shamji , et al.
2019-04-23
Degradation Of Cyclin-dependent Kinase 9 (cdk9) By Conjugation Of Cdk9 Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20190111143 - GRAY; Nathanael S. ;   et al.
2019-04-18
Degradation Of Cyclin-dependent Kinase 8 (cdk8) By Conjugation Of Cdk8 Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20190112307 - GRAY; Nathanael S. ;   et al.
2019-04-18
Degradation Of Cyclin-dependent Kinase 4/6 (cdk4/6) By Conjugation Of Cdk4/6 Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20190092768 - GRAY; Nathanael S. ;   et al.
2019-03-28
C3-carbon Linked Glutarimide Degronimers For Target Protein Degradation
App 20190076542 - Phillips; Andrew J. ;   et al.
2019-03-14
Spirocyclic Degronimers For Target Protein Degradation
App 20190076540 - Phillips; Andrew J. ;   et al.
2019-03-14
Heterocyclic Degronimers For Target Protein Degradation
App 20190076541 - Phillips; Andrew J. ;   et al.
2019-03-14
Amine-linked C3-glutarimide Degronimers For Target Protein Degradation
App 20190076539 - Phillips; Andrew J. ;   et al.
2019-03-14
Inhibitors Of Cyclindependent Kinase 7 (cdk7)
App 20190055248 - Gray; Nathanael S. ;   et al.
2019-02-21
Uses Of Salt-inducible Kinase (sik) Inhibitors
App 20180221379 - Shamji; Alykhan ;   et al.
2018-08-09
Uses Of Salt-inducible Kinase (sik) Inhibitors
App 20170224700 - Shamji; Alykhan ;   et al.
2017-08-10
Imidazolyl Kinase Inhibitors And Uses Thereof
App 20170204082 - Gray; Nathanael S. ;   et al.
2017-07-20
Macrocyclic Kinase Inhibitors And Uses Thereof
App 20170204116 - Gray; Nathanael S. ;   et al.
2017-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed